Status:
RECRUITING
CADASIL Registry Study
Lead Sponsor:
Bin Cai
Conditions:
Cadasil
Eligibility:
All Genders
18-85 years
Brief Summary
The aim of this study is to determine the clinical spectrum and natural progression of Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) and related ...
Eligibility Criteria
Inclusion
- Sign informed consent.
- Age\>18
- Clinical diagnosis of patients with CADASIL,and confirmed by genetic test or skin biopsy
- Asymptomatic NOTCH3 mutation carriers
- Relatives of CADASIL patients or carriers
- Unrelated healthy controls
Exclusion
- Unable to cooperate with inspectors
- Serious systemic illness, such as heart, liver, kidney disease or major mental illness
- Contraindications for imaging examination
Key Trial Info
Start Date :
March 9 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 9 2049
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04310098
Start Date
March 9 2020
End Date
March 9 2049
Last Update
September 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Neurology , First Affiliated Hospital Fujian Medical University
Fuzhou, Fujian, China, 350004